STOCK TITAN

Scientific Industries chair buys 5,000 shares

SCIENTIFIC INDUSTRIES INC (SCND) reported that Chairman of the Board and director John A. Moore purchased 5,000 shares of Common Stock on August 20, 2026 at $0.76 per share in a purchase described as an open-market or private transaction.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SCIENTIFIC INDUSTRIES INC (SCND) reported that Chairman of the Board and director John A. Moore purchased 5,000 shares of Common Stock on August 20, 2026 at $0.76 per share in a purchase described as an open-market or private transaction. Following this transaction, he directly holds 950,641 shares.

Positive

  • None.

Negative

  • None.
Insider MOORE JOHN A
Role Chairman of the Board
Bought 5,000 shs ($4K)
Type Security Shares Price Value
Purchase Common Stock 5,000 $0.76 $4K
Holdings After Transaction: Common Stock — 950,641 shares (Direct)
Shares purchased 5,000 shares Common Stock acquired on August 20, 2026
Purchase price $0.76 per share Price paid for the 5,000-share purchase on August 20, 2026
Holdings after transaction 950,641 shares Direct ownership by John A. Moore after the August 20, 2026 purchase
Net shares bought 5,000 shares Net change in reported non-derivative holdings from the latest transaction
open market financial
"Purchase in open market or private transaction"
An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.
Rule 10b5-1 regulatory
"The report indicates the Rule 10b5-1 trading plan box was not checked"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did SCND report for John A. Moore?

The report shows that John A. Moore, chairman and director of SCIENTIFIC INDUSTRIES INC (SCND), purchased 5,000 shares of Common Stock on August 20, 2026 at $0.76 per share in an open‑market or private transaction.

How many SCND shares does John A. Moore own after this transaction?

After the August 20, 2026 purchase, John A. Moore directly owns 950,641 shares of SCIENTIFIC INDUSTRIES INC Common Stock, according to the reported holdings following the transaction.

At what price were the new SCND shares bought by the chairman?

The 5,000 SCIENTIFIC INDUSTRIES INC (SCND) shares acquired by Chairman John A. Moore on August 20, 2026 were purchased at a price of $0.76 per share, described as a purchase in an open‑market or private transaction.

Was the August 20, 2026 SCND insider purchase under a Rule 10b5-1 plan?

No. The report indicates the Rule 10b5‑1 trading plan box was not checked, so the 5,000‑share purchase of SCIENTIFIC INDUSTRIES INC Common Stock on August 20, 2026 is not affirmed as being made under a Rule 10b5‑1 plan.

What is the net share change from John A. Moore’s latest SCND insider trade?

The latest reported transaction for SCIENTIFIC INDUSTRIES INC (SCND) reflects a net increase of 5,000 shares in John A. Moore’s holdings, all from a single purchase of Common Stock on August 20, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MOORE JOHN A

(Last)(First)(Middle)
403 MARSH LANE

(Street)
WILMINGTON DELAWARE 19807

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SCIENTIFIC INDUSTRIES INC [ scnd ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chairman of the Board
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/20/202608/20/2026P5,000A$0.76950,641D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
John Moore09/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading